PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-218

  1. 815 Posts.
    lightbulb Created with Sketch. 62
    Precisely mate, so hard to find anything risky about PAR.
    Bring on 2020, Once provisional approval is granted, PAR can commercialise ...$$$
    The growth and scale of this business is mind blowing. Cannot ask for a better management team with over 20% skin in the game which align with us shareholders. Once the instos get in and we place in the asx200, $3;00 would look a gift.
    I bought CSL at $30 in 2008 and sold out way too early. Not this time!!
    Last edited by GreatMinds: 15/12/19
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.